Cargando…
P094 IMMUNOLOGIC EFFICACY OF POOLED MESENCHYMAL STEM CELLS IN PATIENTS WITH SEVERE COVID-19-ASSOCIATED PNEUMONIA
Autores principales: | Rynda, A., Hancharou, A., Antonevich, N., Aliakseichyk, S., Pankratova, Y., Isachkin, V., DuBuske, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566849/ http://dx.doi.org/10.1016/j.anai.2021.08.115 |
Ejemplares similares
-
SARS-CoV-2-specific T Cell Immunity after Vaccination with Sputnik V and BBIBP-CorV
por: Babrukevich, Darya, et al.
Publicado: (2022) -
Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro
por: Hancharou, Andrei, et al.
Publicado: (2022) -
Immune Predictors of Death versus Survival in COVID-19 ICU Pneumonia Patients on Mechanical Ventilators
por: Antonevich, Natalia, et al.
Publicado: (2021) -
Blood Dendritic Cells, Monocytes and Myeloid-derived Suppressor Cells in Patients with COVID-19 Associated Pneumonia
por: Hancharou, Andrei, et al.
Publicado: (2021) -
Characterization of T cell, B cell and Natural Killer Cell Subsets in COVID-19 Patients
por: Rynda, Alena, et al.
Publicado: (2021)